World CDx 2026 has ended. This guide stays up as the record of who was there. Next: World CDx 2027, Aug 30 – Sep 2, 2027 in Boston
Pyxis Oncology at World CDx 2026
Oct 5–8, 2026 Boston, MA ~900 attendees Website
Pyxis Oncology takes part in 2 sessions at World CDx 2026 in Boston, its home city. Its sessions cover biomarker strategy for a biotech developing cancer drugs. Most concrete is the search for tissue-based biomarkers of response to micvotabart pelidotin, an antibody-drug conjugate aimed at extradomain-B of fibronectin, a protein in the matrix around tumor cells.
| Organization | World CDx 2026 Attendance |
|---|---|
Pyxis Oncology Boston, MA | |
Clinical-stage oncology biotech developing antibody-drug conjugates, led by micvotabart pelidotin, an ADC targeting extradomain-B of fibronectin in the tumor matrix. | Panel Wed Oct 7 3:10pm Navigating Biomarker Complexity as a Biotech to Build Smarter Precision Oncology Strategies that Maximize Clinical & Commercial Impact Biomarker discovery & translationDrug–diagnostic commercialization & access Talk Thu Oct 8 1:40pm Assessing Histologic Biomarkers of Response to Micvotabart Pelidotin (MICVO), the First-in-Class ADC Targeting the Tumor Extracellular Matrix Protein Extradomain-B of Fibronectin Biomarker discovery & translationDigital pathology & spatial biomarkers |
Instantly find 20 buyers from Pyxis Oncology
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by World CDx or its organizers. Submit a correction